Harvard Bioscience (HBIO) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $8.30 -0.24%
Revenue Growth %: +6.1%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: +6.1%
Financial Fact:
Total operating expenses: 12.5M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q2 EPS of $0.05, $0.01 better than the analyst estimate of $0.04. Revenue for the quarter came in at $28.8 million versus the consensus estimate of $26.6 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Freeport-McMoran (FCX) Tops Q3 EPS by 8c
- Boeing free cash flow beats estimates despite production challenges
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
